Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Chemed Corp. Stock

Price
Target price
?

?

-0.530%
-2.0
-0.530%
€515.26
 
07:31 / Stuttgart Stock Exchange WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Chemed Corp. in the next few years
Wizard

Chemed Corp. Stock

The price for the Chemed Corp. stock decreased slightly today. Compared to yesterday there is a change of -€2.000 (-0.530%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on Chemed Corp..
With a target price of 515 € there is a positive potential of 37.7% for Chemed Corp. compared to the current price of 374.0 €.
So far the community has only identified positive things for Chemed Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
What does Chemed do?

Pros and Cons of Chemed Corp. in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Chemed Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Chemed Corp. -0.530% -1.587% 1.639% -28.462% -25.301% - -
Premier Inc. 0.000% -0.813% 1.667% 14.019% 17.308% - -
Amn Healthcare Svs 0.000% -7.784% -0.645% -58.824% -32.456% -87.581% -70.385%
Ensign Group Inc. -0.640% -1.875% 3.974% 13.768% 23.622% - -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-29

CHEMED CORP's Q2 2025 financial report indicates a strong financial position with significant revenue growth and healthy profitability. Key findings include:

The overall financial trend appears positive, driven by revenue growth and improving profitability.

This analysis provides a factual assessment of CHEMED CORP's financial health based on the provided Q2 2025 financial report data. Investors should consider these factors when evaluating the company's potential future performance.

Show more

Comments

Prediction Buy
Perf. (%) 2.12%
Target price 494.894
Change
Ends at 10.11.26

Chemed (NYSE:CHE) had its price target lowered by analysts at Royal Bank Of Canada from $589.00 to $572.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Show more

Royal Bank of Canada 
0
Report Share
10.11.25
Prediction Buy
Perf. (%) -1.03%
Target price 508.666
Change
Ends at 10.09.26

Chemed (NYSE:CHE) had its price target lowered by analysts at Bank of America Corporation from $610.00 to $595.00. They now have a "buy" rating on the stock.
Ratings data for CHE provided by MarketBeat
Show more

Bank of America Co. 
0
Report Share
10.09.25
Prediction Buy
Perf. (%) -2.03%
Target price 469.975
Change
Ends at 02.09.26

Chemed (NYSE:CHE) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $550.00 price target on the stock, up previously from $490.00.
Ratings data for CHE provided by MarketBeat
Show more

Jefferies Financial Group Inc. 
0
Report Share
02.09.25
Show more
Not a member yet? Sign up for free!

News

Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million: https://g.foolcdn.com/misc-assets/institutional.png
Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million

Schwartz Investment Counsel disclosed that it reduced its position in Chemed Corporation (NYSE:CHE) by 28,771 shares during the quarter, according to a 13F form filed with the Securities and

TheMotleyFool 
0 02.11.25
EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/040b843d3831400081133d79e62d75c0988608c3-5263x3509.jpg?w=5263&h=3509
EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too?

On October 28, 2025, EULAV Asset Management reported selling 28,313 shares of Chemed (NYSE:CHE) in Q3 2025, an estimated $12.82 million trade based on the average price during Q3 2025.

According to

TheMotleyFool 
0 30.10.25
Why Chemed Stock Is Plummeting Today
Why Chemed Stock Is Plummeting Today

Chemed (NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market

TheMotleyFool 
0 30.07.25